Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen Leehey

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2011
Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriersDeborah Hall, Flora Tassone, Olga Klepitskaya, et al.
Neurology. Clinical Practice|December 20, 2013
Primary dystonia misinterpreted as Parkinson disease: Video case presentation and practical cluesOlga Klepitskaya, Alexander J Neuwelt, Tam Nguyen, et al.
Current Medical Research and Opinion|April 5, 2007
Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's diseaseMark F Lew, Rajesh Pahwa, Maureen Leehey, et al.
Handbook of Clinical Neurology|September 24, 2008
TransplantationCurt R Freed, W Michael Zawada, Maureen Leehey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 2, 2018
Age- and CGG repeat-related slowing of manual movement in fragile X carriers: A prodrome of fragile X-associated tremor ataxia syndrome?Ryan Shickman, Jessica Famula, Flora Tassone, et al.
Annals of Neurology|May 6, 2003
Tremor and ataxia in fragile X premutation carriers: blinded videotape studyElizabeth Berry-Kravis, Foster Lewin, Joanne Wuu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 28, 2016
Levodopa modulates small-world architecture of functional brain networks in Parkinson's diseaseBrian D Berman, Jason Smucny, Korey P Wylie, et al.
Plos One|February 14, 2020
Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS)Deborah A Hall, Erin E Robertson, Maureen Leehey, et al.
Journal of the Neurological Sciences|June 12, 2016
Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North AmericaJohn L Goudreau, Adriana Pérez, Michael J Aminoff, et al.
Journal of Analytical Toxicology|March 23, 2021
Simultaneous Quantification of 17 Cannabinoids by LC-MS-MS in Human PlasmaCristina Sempio, Nohemi Almaraz-Quinones, Matthew Jackson, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2011
Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriersDeborah Hall, Flora Tassone, Olga Klepitskaya, et al.
Neurology. Clinical Practice|December 20, 2013
Primary dystonia misinterpreted as Parkinson disease: Video case presentation and practical cluesOlga Klepitskaya, Alexander J Neuwelt, Tam Nguyen, et al.
Current Medical Research and Opinion|April 5, 2007
Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's diseaseMark F Lew, Rajesh Pahwa, Maureen Leehey, et al.
Handbook of Clinical Neurology|September 24, 2008
TransplantationCurt R Freed, W Michael Zawada, Maureen Leehey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 2, 2018
Age- and CGG repeat-related slowing of manual movement in fragile X carriers: A prodrome of fragile X-associated tremor ataxia syndrome?Ryan Shickman, Jessica Famula, Flora Tassone, et al.
Annals of Neurology|May 6, 2003
Tremor and ataxia in fragile X premutation carriers: blinded videotape studyElizabeth Berry-Kravis, Foster Lewin, Joanne Wuu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 28, 2016
Levodopa modulates small-world architecture of functional brain networks in Parkinson's diseaseBrian D Berman, Jason Smucny, Korey P Wylie, et al.
Plos One|February 14, 2020
Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS)Deborah A Hall, Erin E Robertson, Maureen Leehey, et al.
Journal of the Neurological Sciences|June 12, 2016
Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North AmericaJohn L Goudreau, Adriana Pérez, Michael J Aminoff, et al.
Journal of Analytical Toxicology|March 23, 2021
Simultaneous Quantification of 17 Cannabinoids by LC-MS-MS in Human PlasmaCristina Sempio, Nohemi Almaraz-Quinones, Matthew Jackson, et al.
Pageof 2